Passage Bio Terminates Lease Agreement with Hopewell Campus Owner LLC
Mar 10, 2026
Contract Type
lease_termination
United StatesBiotechnologyHealthcareHealth CareGeneticsTherapeutics
Description
On March 4, 2026, Passage Bio, Inc. and Hopewell Campus Owner LLC finalized a lease termination agreement concerning the Hopewell Lease. The agreement stipulates a termination fee of approximately $4.8 million, including accrued rent until February 14, 2026. The original lease covered about 62,000 square feet of laboratory space
Company Information
Company
Passage Bio
Location
United States
About
Passage Bio, Inc. (NASDAQ: PASG) is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases.